Article
Associations of TIMP-3 Genetic Polymorphisms with EGFR Statuses and Cancer Clinicopathologic Development in Lung Adenocarcinoma Patients.
International journal of molecular sciences - 28 Oct 2020
Chang Jer-Hwa, Lai Tsung-Ching, Yang Po-Jen, Shih Pei-Chun, Yang Yi-Chieh, Lee Kai-Ling, Liu Tu-Chen, Tsao Thomas Chang-Yao, Yang Shun-Fa, Chien Ming-Hsien
Abstract excerpt
Lung adenocarcinoma (LADC) is a major subtype of lung cancer, particularly among populations of East Asia. The epidermal growth factor receptor (EGFR) is the most frequently mutated oncogene promoting LADC progression and can serve as a therapeutic target in LADC. The tissue inhibitor of metalloproteinases (TIMP)-3 is a major regulator of extracellular matrix turnover via targeting of matrix metalloproteinases...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
